Dr. Wolfgang Bender is Valneva’s acting Chief Medical Officer.
After his medical training, Dr. Bender started his biopharmaceutical career in clinical research and development and advanced through positions of increasing responsibility in strategic planning, corporate and general management, and scientific medical affairs. He lived and worked more than 10 years in developing and in tropical countries.
Dr. Bender holds a medical degree and a doctorate (laboratory diagnostics) from the Johannes-Gutenberg-University, Mainz, master degrees in public health and health administration from the University of New South Wales, Sydney, and a diploma in tropical medicine and parasitology from the Bernhardt-Nocht-Institute, Hamburg.
· Rising incidence and further geographic spread of the disease
· VLA 1553 pre-clinical data, PhI trial design and market potential